- Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A dual threat to cardiac dysfunction progression
- Browse: 23 Download: 55 Issue Date: 2025-01-21
- Predictive value of the systemic immune inflammation index in recurrence of atrial fibrillation after radiofrequency catheter ablation
- Browse: 21 Download: 55 Issue Date: 2025-01-21
- Known yet underdiagnosed: Invasive assessment of coronary microvascular disease and its implications
- Browse: 30 Download: 63 Issue Date: 2025-01-21
- Global hotspots and trends on environmental exposure and cardiovascular disease from 1999 to 2022
- Browse: 19 Download: 56 Issue Date: 2025-01-21
- Profiling and bioinformatics analyses of circular RNAs in myocardial ischemia/reperfusion injury model in mice
- Browse: 22 Download: 82 Issue Date: 2025-01-21
- Right ventricular diverticulum following a pulmonary valve placement for correction of tetralogy of Fallot: A case report
- Browse: 73 Download: 168 Issue Date: 2024-11-26
- Nocturnal sentry duty and cardiometabolic characteristics in armed forces personnel
- Browse: 82 Download: 163 Issue Date: 2024-11-26
- Independent prognostic value of lipocalin-2 in congenital heart disease associated pulmonary artery hypertension
- Browse: 65 Download: 158 Issue Date: 2024-11-26
- E-cigarettes and arterial health: A review of the link between vaping and atherosclerosis progression
- Browse: 63 Download: 116 Issue Date: 2024-11-26
- Balancing bleeding, thrombosis and myocardial injury: A call for balance and precision medicine for aspirin in neurosurgery
- Browse: 74 Download: 117 Issue Date: 2024-11-26
- SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threat
- Browse: 56 Download: 105 Issue Date: 2024-10-31
- Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure
- Browse: 51 Download: 115 Issue Date: 2024-10-31
- Kill two birds with one stone: Hapatologist’s approach to metabolic dysfunction-associated steatotic liver disease and heart failure
- Browse: 55 Download: 83 Issue Date: 2024-10-31
- Impact of single chamber and dual chamber permanent pacemaker implantation on left ventricular function: An observational study
- Browse: 56 Download: 124 Issue Date: 2024-10-31
- Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure
- Browse: 50 Download: 100 Issue Date: 2024-10-31
- Effectiveness and mechanisms of sodium-dependent glucose transporter 2 inhibitors in type 2 diabetes and heart failure patients
- Browse: 86 Download: 129 Issue Date: 2024-10-17
- Evaluating neuromuscular electrical stimulation for preventing and managing intensive care unit-acquired weakness: Current evidence and future directions
- Browse: 83 Download: 109 Issue Date: 2024-10-17
- Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
- Browse: 98 Download: 184 Issue Date: 2024-10-17
- Percutaneous decannulation of extracorporeal membrane oxygenation using MANTA device: A real-world single-center experience
- Browse: 84 Download: 172 Issue Date: 2024-10-17
- Sodium glucose cotransporter 2 inhibitors in the management of heart failure: Veni, Vidi and Vici
- Browse: 101 Download: 147 Issue Date: 2024-10-17